Please login to the form below

Not currently logged in
Email:
Password:

GAD

This page shows the latest GAD news and features for those working in and with pharma, biotech and healthcare.

Pear Therapeutics submits latest digital therapeutic, insomnia and depression treatment

Pear Therapeutics submits latest digital therapeutic, insomnia and depression treatment

Pear Therapeutics says the study also showed improvements in anxiety symptoms (as measured by the General Anxiety Disorder 7-item (GAD-7) scale), with a treatment arm mean of 3.16

Latest news

  • Chasing the cure for Parkinson's disease Chasing the cure for Parkinson's disease

    NLX P101 uses adeno-associated virus-mediated transfer to introduce the gene for GAD into the brain. ... GAD converts glutamate (ie main excitatory neurotransmitter) into gamma-aminobutyric acid (GABA; main inhibitory neurotransmitter).

  • Pfizer uses augmented reflection technology for mental health campaign Pfizer uses augmented reflection technology for mental health campaign

    Teams up with Anxiety UK to raise awareness of GAD.  . One of the striking images from Pfizer's video  . Pfizer UK has launched a new campaign that uses augmented reflection technology ... In Pfizer's case, as the new Let's Talk about GAD video shows,

  • Diabetes favoured

    GAD 65 antigen based. therapy for type 1 diabetes. Ongoing phase III.

  • An unexpected turn

    Quetiapine was launched for the treatment of schizophrenia and bipolar disorders, and is currently in preregistration for the treatment of depression and generalised anxiety disorder (GAD) in the US, with supplemental ... In another trial, patients with

  • Beating the system

    NLX-P101 uses an adeno-associated virus to carry the glutamic acid decarboxylase (GAD) gene into the neurones of the subthalamic nucleus - the part of the brain that is over-stimulated

More from news
Approximately 1 fully matching, plus 5 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Envision Pharma Group

We are a global leader in the medical affairs space. Our purpose-built software and scientific solutions make us a unique...

Latest intelligence

Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
Employee wellbeing in creative agencies: three tips to get you started
Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
Managing unhelpful pressure in your creative agency: the human approach
Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...